COVID-19 Parental Vaccine Hesitancy in Romania: Nationwide Cross-Sectional Study

Manolescu, Loredana Sabina Cornelia; Zaharia, Corneliu; Dumitrescu, Anca; Prasacu, Irina; Radu, Mihaela Corina; Boeru, Adrian Calin; Boidache, Liliana; Niţă, Irina; Necsulescu, Andrei; Medar, Cosmin; Cristache, Corina Marilena; Chivu, R D

doi:10.3390/vaccines10040493

Cited by 19 publications

(24 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the present survey demonstrates that parents' concerns about adverse effects of the vaccination were the biggest doubt before the vaccination. This is consistent with the findings of several previous studies, local and abroad, also regarding the willingness or hesitancy of the vaccination ( 11 – 13 , 21 , 22 ). However, this finding is surprising particularly because it has been observed worldwide that the most reported adverse events of the COVID-19 vaccination in children and adolescents, particularly with the mRNA vaccines, were mild in severity and short in duration ( 23 , 24 ).…”

Section: Discussionsupporting

confidence: 93%

Parents' reasons to vaccinate their children aged 5–11 years against COVID-19 in Italy

et al. 2022

View full text Add to dashboard Cite

ObjectivesThe aims of this cross-sectional study were to investigate why parents decide to vaccinate, as well as the determinants, their children aged 5–11 years against COVID-19 in Italy.MethodsThe survey was conducted from January through May 2022. All parents/guardians who came in randomly selected days to immunization centers for the administration of the first dose of the COVID-19 vaccine to their child were asked to complete a questionnaire about socio-demographic characteristics, attitudes toward COVID-19 infection and vaccination, reason(s) regarding their decision to vaccinate their child, and source(s) of information.ResultsA total of 358 questionnaires were collected. Parent's perception that COVID-19 is a severe illness for the child, assessed using a 10-point Likert scale, was 7.5. The overall mean scores of the risk perception for their child of having the COVID-19 before and after the vaccination were 8.1 and 6.3. A significantly higher parents' level of risk perception for their child of having the COVID-19 after the vaccination has been observed among those not having a university degree, those with the child having at least one chronic medical condition, and those who perceived that COVID-19 is a severe illness for the child. The mean value of respondent trust in the information provided by the pediatricians on a 10-point scale Likert type was 7.6. Female, not having a university degree, higher perception that COVID-19 is a severe disease, not having received information about the vaccination from pediatricians, and needing information had a significantly higher concern of side effects after the vaccination. The most common reasons for vaccinating their children included wanting to protect the child against COVID-19, to attend the school with less risk, to prevent the transmission to family members, and to practice sport and other activities with less risks. Participants with a university degree were more likely to have vaccinated their child for attending the school and practicing sport and other activities with less risks.ConclusionsMore publicity should be promoted among parents of children aged 5–11 years which would increase the coverage rates and thus lower the transmission of SARS-CoV-2 and reduce the occurrence of COVID-19.

show abstract

Section: Discussionsupporting

confidence: 93%

Parents' reasons to vaccinate their children aged 5–11 years against COVID-19 in Italy

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Even if the perception of risk depends on personal traits, such as neuroticism and conscientiousness [ 49 ], resilience training, inside the organization, has been proven beneficial for coping with the challenges imposed by the COVID-19 pandemic [ 50 ]. In fact, like our findings, concerns about COVID-19 were more important than the actual risk of infection at work in predicting insomnia [ 51 , 52 , 53 , 54 , 55 , 56 ].…”

Section: Discussionsupporting

confidence: 77%

Coronasomnia in Employees without a Direct Contact with COVID-19 Infected Patients in Their Workplace

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background: The aim of this analysis was to explore coronasomnia in second line workers. Methods: Data were collected via in an online questionnaire. Patients with new onset or aggravation of insomnia were defined as cases and those without insomnia as controls. Differences among groups were studied by nonparametric tests; the correlation among variables was assessed using regression, followed by Bonferroni adjustment. Results: There were 377 responders, grouped into 129 cases and 248 controls. Younger age (Odds Ratio = 0.97, p = 0.021), women (OR = 2.46, p = 0.016), workers belonging to a vulnerable group (OR = 2.36, p = 0.007), and those with previous history of insomnia (OR = 38.76, p = 0.00) were associated with coronasomnia. Increased home duties were directly related to insomnia (OR = versus home support which were indirectly associated). The constant preoccupation for SARS-CoV-2 media reports (OR = 3.6, p = 0.00009) and media consumption were components of the coronasomnia. In the adjusted models, the personal medical history, and the anxiety created by media alerts maintained their significance. Conclusion: Preventive measures to reduce the occurrence of insomnia in times of social stress in nonessential occupations should focus on health vulnerable groups, persons with previous history of insomnia and who develop anxiety from media.

show abstract

“…A more restrictive definition considers that VH refers precisely to “preoccupations regarding vaccines, irrespective of the actual vaccination” [ 2 ]. In Romania, the VH phenomenon was on the rise in the context of the SARS-CoV-2 pandemic, and it was visible in the case of various population categories [ 3 , 4 , 5 , 6 ]. The vaccination rate in East-European countries, such as Romania, was much lower than in the rest of the European Union, and it led to challenges and extreme pressure on the medical system [ 7 , 8 , 9 , 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

The Multidimensional Vaccine Hesitancy Scale: A Validation Study

et al. 2022

View full text Add to dashboard Cite

Vaccination hesitancy (VH) is a phenomenon which increases the occurrence of vaccine-preventable diseases. The study tests the validity of the Multidimensional Vaccine Hesitancy Scale (MVHS) in the case of a sample of Romanian adults (n = 528; Meanage = 30.57). The latter filled in an online cross-sectional survey. The construct validity of MVHS was assessed by using confirmatory factor analysis (CFA), the reliability was calculated by using the internal consistency, and the convergent and discriminant validity was assessed by using the composite reliability (CR), and average variance extracted (AVE). The obtained model was invariant across gender. The structural equation model was designed for predictive validity by using the partial least square method (PLS-SEM) which analyses the relation between the MVHS dimensions and the vaccination willingness. The results show support for the 8-factor structure of the scale (χ2/df = 2.48; CFI = 0.95; RMSEA = 0.053). The Cronbach’s coefficients α > 0.70; McDonald’s ω > 0.70 and CR > 0.80 have very good values. The structural equation model shows that there are more dimensions of the scale which predict vaccination hesitancy in various types of vaccines—the main predictors remain the dimensions of health risk and healthy condition. The study’s conclusion led to the idea that the MVHS is suitable for medical practice and for research on the analysis of vaccination behaviours and intentions.

show abstract

COVID-19 Parental Vaccine Hesitancy in Romania: Nationwide Cross-Sectional Study

Cited by 19 publications

References 40 publications

Parents' reasons to vaccinate their children aged 5–11 years against COVID-19 in Italy

Parents' reasons to vaccinate their children aged 5–11 years against COVID-19 in Italy

Coronasomnia in Employees without a Direct Contact with COVID-19 Infected Patients in Their Workplace

The Multidimensional Vaccine Hesitancy Scale: A Validation Study

Contact Info

Product

Resources

About